Here are the 10-Q quarterly reports from SunOpta, Inc. (STKL) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow STKL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full STKL filings page.
SunOpta Inc. (STKL) reported Q3 FY2025 results. Revenue was $205.4M, up 16.8% year over year, with operating income of $6.9M and diluted EPS of $0.01. Gross margin was 12.4% (down 60 bps), reflecting labor and infrastructure investments, depreciation on newly placed assets, tariff pass-through effects, and inefficiencies tied to temporary volume constraints at the Midlothian, Texas facility.
Through the first three quarters, revenue reached $598.5M (+13.0%), operating income $27.9M, and net earnings $10.0M. Q3 adjusted EBITDA was $23.6M (vs. $20.8M a year ago). Net interest expense fell to $5.4M on lower borrowings and better rates. The company repurchased 163,227 shares for $1.0M and ended Q3 with 118.2M common shares outstanding as of October 31, 2025.
Liquidity included $166.5M outstanding on the term loan, $34.4M on the revolver (with $4.9M in LCs issued), and a fully drawn $15.0M broth inventory line. Management projects higher year-over-year revenues and an improved gross margin profile, while noting certain manufacturing inefficiencies and temporary volume constraints may continue to affect reported margins.
SunOpta (STKL) posted a solid turnaround in Q2-25. Revenue rose 12.9% YoY to $191.5 million, led by double-digit beverage, broth and fruit-snack volume gains. Gross margin expanded 230 bps to 14.8%, lifting gross profit to $28.4 million. Operating income jumped to $10.5 million from $2.0 million, and diluted EPS from continuing ops improved to $0.03 versus a $(0.04) loss.
For the first half, sales reached $393.1 million (+11.1%), net income $9.2 million (vs. a $(0.6) million loss) and diluted EPS $0.07. Operating cash flow was $17.8 million.
Balance sheet/liquidity: cash & equivalents $2.2 million plus $8.0 million restricted; long-term debt $233.1 million; leverage compliant with covenants. A $15 million trade loan, $85 million revolver ($40.7 million drawn) and $180 million term loan backstop liquidity. A $25 million share-repurchase plan began in Q2; 163,227 shares ($1.0 million) were bought, leaving $24 million authorized.
Key developments: 90 bp gross-margin drag from U.S. tariff timing; $6.7 million CBP duty accrual outstanding; receivables-sale program expanded to $42 million (sold balance $37.6 million). Company targets margin recovery via price pass-throughs, supply-chain efficiencies and increased plant utilization.